Brief: Bioarctic AB Says Leqembi Approved For Treatment Of Alzheimer's Disease In Hong Kong
11/07/2024 24:32
July 10 (Reuters) - BioArctic AB BIOAb.ST :
* BIOARCTIC AB- LEQEMBI APPROVED FOR TREATMENT OF
ALZHEIMER'S
DISEASE IN HONG KONG
Source text for Eikon: ID:nWkrbRRydk
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million